1 reports of this reaction
16.7% of all METHYL SALICYLATE, MENTHOL reports
#5 most reported adverse reaction
RASH PRURITIC is the #5 most commonly reported adverse reaction for METHYL SALICYLATE, MENTHOL, manufactured by Accord Healthcare, Inc.. There are 1 FDA adverse event reports linking METHYL SALICYLATE, MENTHOL to RASH PRURITIC. This represents approximately 16.7% of all 6 adverse event reports for this drug.
Patients taking METHYL SALICYLATE, MENTHOL who experience rash pruritic should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH PRURITIC is a frequently reported adverse event for METHYL SALICYLATE, MENTHOL, accounting for a significant proportion of all reports.
In addition to rash pruritic, the following adverse reactions have been reported for METHYL SALICYLATE, MENTHOL:
The following drugs have also been linked to rash pruritic in FDA adverse event reports:
RASH PRURITIC has been reported as an adverse event in 1 FDA reports for METHYL SALICYLATE, MENTHOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH PRURITIC accounts for approximately 16.7% of all adverse event reports for METHYL SALICYLATE, MENTHOL, making it a notable side effect.
If you experience rash pruritic while taking METHYL SALICYLATE, MENTHOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.